James Basta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Contrarius Investment Management Ltd decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 214,401 shares of the company’s stock after selling 17,461 shares during the quarter. Contrarius Investment Management Ltd owned […]

Merlin Capital Inc raised its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 44.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 26,834 shares of the company’s stock after acquiring an additional 8,308 shares during the period. Intellia Therapeutics makes up 2.6% of Merlin Capital Inc’s investment portfolio, making the stock […]

Merlin Capital Inc lifted its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 44.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,834 shares of the company’s stock after buying an additional 8,308 shares during the period. Intellia Therapeutics comprises […]

Jennison Associates LLC grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 26.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,848 shares of the company’s stock after purchasing an additional 4,949 shares during the period. Jennison Associates LLC’s holdings in […]

Abrdn plc bought a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 154,269 shares of the company’s stock, valued at approximately $4,704,000. abrdn plc owned about 0.17% of Intellia Therapeutics as […]